The pharmaceutical company Wellgistics Health Inc. has announced a credit line of $50 million to integrate XRP into its financial operations. The goal of this initiative is to increase transaction speed and transparency in its network.
As a result, XRP will be used as a treasury reserve asset and a real-time payment method, making Wellgistics Health Inc. one of the first publicly traded medical companies with such integration.
Transaction processing in the XRP ledger takes 3-5 seconds at a cost of less than $0.0002 — this is a significant advantage over bank payments.
CEO Brian Norton of the company, which has already signed over 150 direct contracts with manufacturers and has a network of more than 6000 pharmacies nationwide, emphasized that this step contributes to the modernization of payments in the healthcare system.
It is quite likely that institutional adoption of XRP has been spurred by the launch of XRP futures by CME Group and recognition of the token by payment giant Mastercard as an intermediary currency for cross-border payments.
